CAPB; DRT; EK2; EK5; EK6; ELK; elk related tyrosine kinase; EPH like kinase 2; EPH like kinase 6; EPH like tyrosine kinase 2; eph tyrosine kinase 2; eph tyrosine kinase 3; EPH-like kinase 6; Ephb1; EPHB1_HUMAN; EPHB2; EPHB3; EPHB4; ephrin receptor EphB4; ephrin type B receptor 1; ephrin type B receptor 2; ephrin type B receptor 3; ephrin type B receptor 4; Ephrin type-B receptor 1; EPHT2; EPHT3; ERK; ETK2; Hek 5; Hek 6; HEK2; HEK5; HEK6; hepatoma transmembrane kinase; HTK; human embryo kinase 2; MYK1; NET; PCBC; protein tyrosine kinase HEK5; renal carcinoma antigen NY REN 47; soluble EPHB1 variant 1; soluble EPHB4 variant 1; soluble EPHB4 variant 2; soluble EPHB4 variant 3; TYRO11; Tyro5; TYRO6; tyrosine protein kinase receptor EPH 2; tyrosine protein kinase receptor EPH 3; tyrosine protein kinase receptor EPH2; tyrosine protein kinase receptor EPH3; tyrosine protein kinase receptor HTK; tyrosine protein kinase TYRO11; tyrosine protein kinase TYRO5; tyrosine protein kinase TYRO6; Tyrosine-protein kinase receptor EPH-2.